TIVC
Tivic Health Systems, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.02
P/S
2.75
EV/EBITDA
0.65
DCF Value
$-4.98
FCF Yield
-91.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
8.4%
Operating Margin
-2067.5%
Net Margin
-2324.1%
ROE
-122.0%
ROA
-28.1%
ROIC
-25.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $-302.0K | $6.0M | $6.68 |
| FY 2025 | $382.0K | $-8.9M | $0.00 |
| Q3 2025 | $146.0K | $-2.6M | $-1.97 |
| Q2 2025 | $86.0K | $-1.9M | $-2.19 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.84
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.